USANA HEALTH SCIENCES INC
Calidad de datos: 100%
USNA
NYSE
Manufacturing
Chemicals
$18.38
▲
$0.31
(1.72%)
Cap. Mercado: 339.24 M
Precio
$18.38
Cap. Mercado
339.24 M
Rango del Día
$17.60 — $18.38
Rango de 52 Semanas
$16.60 — $38.32
Volumen
64,483
Apertura $17.91
Promedio 50D / 200D
$19.46
5.57% below
Promedio 50D / 200D
$24.02
23.49% below
Quick Summary
Puntos Clave
Earnings declined -83.13% over the past year
ROE of 2.03% is below average
Generating 8.53 M in free cash flow
P/E of 31.53 — premium valuation
Capital efficient — spends only 1.49% of revenue on capex
ROIC of 3.07% — low return on invested capital
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)0.46%
Earnings (1Y)-83.13%
FCF Growth (3Y)-69.80%
Calidad
Return on Equity
2.03%
Above sector avg (-51.02%)
ROIC3.07%
Net Margin1.16%
Op. Margin4.05%
Seguridad
Debt / Equity
N/A
Current Ratio2.23
Interest Coverage44.46
Valoración
PE (TTM)
31.53
Above sector avg (-1.98)
P/B Ratio0.64
EV/EBITDA2.77
Dividend YieldN/A
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Manufacturing (44 pares)
Comparación con Pares
vs mediana del sector Manufacturing (44 pares)| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 31.5 | -2.0 |
| P/B | 0.6 | 5.1 |
| ROE % | 2.0 | -51.0 |
| Net Margin % | 1.2 | -150.2 |
| Rev Growth 5Y % | — | 9.3 |
| D/E | — | 0.3 |
ETFs Holding This Stock
0.93% weight
0.33% weight
0.09% weight
0.06% weight
0.05% weight
0.05% weight
0.05% weight
0.04% weight
0.02% weight
0.00% weight
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0.46% | Revenue Growth (3Y) | -3.74% |
| Earnings Growth (1Y) | -83.13% | Earnings Growth (3Y) | -60.61% |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 925.26 M | Net Income (TTM) | 10.76 M |
| ROE | 2.03% | ROA | 1.47% |
| Gross Margin | 78.29% | Operating Margin | 4.05% |
| Net Margin | 1.16% | Free Cash Flow (TTM) | 8.53 M |
| ROIC | 3.07% | FCF Growth (3Y) | -69.80% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2.23 |
| Interest Coverage | 44.46 | Asset Turnover | 1.27 |
| Working Capital | 145.40 M | Tangible Book Value | 245.63 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 31.53 | Forward P/E | N/A |
| P/B Ratio | 0.64 | P/S Ratio | 0.37 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | 2.77 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 2.51% | ||
| Market Cap | 339.24 M | Enterprise Value | 193.89 M |
| Per Share | |||
| EPS (Diluted TTM) | 0.58 | Revenue / Share | 50.13 |
| FCF / Share | 0.46 | OCF / Share | 1.21 |
| EPS CAGR (1Y) | -82.42% | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | -19.29% | ||
| Efficiency | |||
| CapEx / Revenue | 1.49% | FCF Conversion | 79.24% |
| SBC-Adj. FCF | -5.09 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2023 | FY2022 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | 925.26 M | 921.01 M | 998.60 M | 1.13 B | 1.06 B |
| Net Income | 10.76 M | 63.79 M | 69.35 M | 124.66 M | 100.53 M |
| EPS (Diluted) | 0.58 | 3.30 | 3.59 | 5.86 | 4.41 |
| Gross Profit | 724.41 M | 744.32 M | 804.71 M | 925.53 M | 873.40 M |
| Operating Income | 37.43 M | 93.07 M | 107.61 M | 176.49 M | 146.19 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 10.69 M | 11.45 M | 11.56 M | 10.63 M | 10.26 M |
| SG&A Expenses | 337.37 M | 256.99 M | 262.30 M | 261.19 M | 267.73 M |
| D&A | 32.56 M | 12.70 M | 13.39 M | 13.75 M | 14.74 M |
| Interest Expense | 842,000.0 | 262,000.0 | 192,000.0 | 507,000.0 | 66,000.0 |
| Income Tax | 30.05 M | 38.67 M | 39.27 M | 53.28 M | 49.97 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2023 | FY2022 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Total Assets | 742.92 M | 632.76 M | 596.55 M | 640.89 M | 516.93 M |
| Total Liabilities | 156.64 M | 135.56 M | — | — | — |
| Shareholders' Equity | 533.10 M | 497.20 M | 434.47 M | 441.65 M | 351.71 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 158.38 M | 330.42 M | 288.42 M | 311.92 M | 234.83 M |
| Current Assets | 288.41 M | 417.75 M | 384.38 M | 425.29 M | 329.28 M |
| Current Liabilities | 128.57 M | 118.85 M | 143.83 M | 168.07 M | 136.10 M |
{"event":"ticker_viewed","properties":{"ticker":"USNA","listing_kind":"stock","pathname":"/stocks/usna","exchange":"NYSE","country":"US"}}